BioCentury | Jan 13, 2017
Emerging Company Profile

Conditional replication

...$61 million Investors: MPM Capital, Deerfield Management, Arkin Bio Ventures, Celgene Corp. , Excelyrate Capital, Long March Investment Fund...
BioCentury | Jul 25, 2016
Financial News

Oncorus completes venture financing

...Raised: $57 million Investors: MPM Capital; Deerfield Management; Arkin Holdings; Celgene Corp. ; Excelyrate Capital; Long March Investment Fund WIR...
BioCentury | Jul 19, 2016
Financial News

Oncolytic virus play Oncorus raises $57M

...led by MPM Capital. Deerfield Management, Arkin Bio Ventures, Celgene Corp. (NASDAQ:CELG), Excelyrate Capital, and Long March Investment Fund...
Items per page:
1 - 3 of 3
BioCentury | Jan 13, 2017
Emerging Company Profile

Conditional replication

...$61 million Investors: MPM Capital, Deerfield Management, Arkin Bio Ventures, Celgene Corp. , Excelyrate Capital, Long March Investment Fund...
BioCentury | Jul 25, 2016
Financial News

Oncorus completes venture financing

...Raised: $57 million Investors: MPM Capital; Deerfield Management; Arkin Holdings; Celgene Corp. ; Excelyrate Capital; Long March Investment Fund WIR...
BioCentury | Jul 19, 2016
Financial News

Oncolytic virus play Oncorus raises $57M

...led by MPM Capital. Deerfield Management, Arkin Bio Ventures, Celgene Corp. (NASDAQ:CELG), Excelyrate Capital, and Long March Investment Fund...
Items per page:
1 - 3 of 3